The ASHM Scholarship Program offered scholarships to HIV s100 prescribers (GP/Primary care), Sexual Health Physicians & Hospital Based Specialists managing HIV to attend CROI 2017 (Conference on Retroviruses and Opportunistic Infections) held from 13-16 February, 2017 in Seattle, Washington.
On this webpage, click through to the reports on key learnings authored by the scholarship-awarded clinicians focussing particularly on HIV therapy, HIV comorbidities, and HIV immunepathogenesis:
Robert Burton studied medicine a St George's Hospital Medical School, University of London before going on to specialise in general practice. Having undertook GP training through University College London Hospitals, it was during this time that his interest in sexual health was sparked after working in a busy London sexual health clinic. After completing GP specialty training, he moved to Sydney and began work as a registrar at Sydney Sexual Health Centre, Sydney Hospital. Robert spent two years at Sydney Sexual Health Centre (SSHC), during which time he completed the s100 HIV prescriber course. From May 2014 he joined Taylor Square Private Clinic and particularly enjoys the opportunity to work in this high case-load practice where he combines his joint interests in sexual health/HIV medicine and general practice.
Read Robert's report back from CROI:
Wei Cai is a general practitioner at Maxcare Clinic Darlinghurst, Sydney with a special interest in HIV treatment and prevention, as well as GP training education.
Read Wei's report back from CROI:
Go back to the top of the page
Virginia Furner has 30 years clinical experience in HIV care, treatment, and research and currently provides care for extremely complex patients with longstanding HIV infection. She has special interests relating to the care of women with HIV and pregnancy, adolescent transition to adult care and the care of urban HIV-infected indigenous men and women. In addition, she has extensive experience in undergraduate and postgraduate teaching and the clinical teaching of general practitioners participating in ASHM's training to become S100 prescribers of HIV antiretroviral medications. For many years she has worked collaboratively with the affected community, being involved in numerous activities for people living with HIV, working with NAPWHA, PozHet and ACON throughout NSW and across Australia. She was a member of the previously constituted Ministerial Advisory Committee for NSW Health and is currently on the Ministerial Committee for the implementation of the HIV strategic plan for NSW, focussing on Treatment as Prevention.
Read Virginia's report back from CROI:
Richard Moore is a general practitioner who has worked in the HIV field for many years. He is also on the staff at Alfred Hospital and Melbourne Sexual Health Centre.
Read Richard's report back from CROI:
Mark O'Reilly is an s100 HIV/HCV Specialist GP working at Prahran Market Clinic in Melbourne. He is also a Sexual Health Advanced Trainee at the Action Centre (Family Planning Victoria). Interests include HIV prevention, HIV/HCV co-infection and managing issues relating to drug use in the context of sex.
Read Mark's report back from CROI:
Mike is a general practitioner and community HIV s100 prescriber at Gungahlin Family Healthcare in Canberra. He has been involved in the clinical care of HIV positive people since 2003. Mike works closely with other health and community providers in Canberra to coordinate HIV care. He has participated in the panel adapting the US Antiretroviral Guidelines and lectured on lesbian, gay and transgender issues in the Australian Defence Force. Mike has a strong interest in men's health, HIV treatment and sexually transmitted disease prevention.
CROI 2017: Seattle
The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI is a global model of collaborative science and the premier international venue for bridging basic and clinical investigation to clinical practice in the field of HIV and related viruses.